Eur J Heart Fail. 2026 Mar 12:xuag035. doi: 10.1093/ejhf/xuag035. Online ahead of print.ABSTRACTHypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease and a leading cause of heart failure and sudden cardiac death (SCD) in young adults. Given its complex pathophysiology, pheno
JACC Clin Electrophysiol. 2026 Mar 9:S2405-500X(26)00127-1. doi: 10.1016/j.jacep.2026.01.052. Online ahead of print.ABSTRACTBACKGROUND: The automatic implantable cardioverter-defibrillator (ICD) is effective in preventing arrhythmic sudden cardiac death in patients with hypertrophic cardiomyopathy (
Radiol Cardiothorac Imaging. 2026 Apr;8(2):e250471. doi: 10.1148/ryct.250471.ABSTRACTSurgical treatment of hypertrophic obstructive cardiomyopathy is challenging. It requires balancing adequate myocardial excision against the risk of excessive resection, which can result in an iatrogenic ventricular
JACC Case Rep. 2026 Mar 11;31(10):107254. doi: 10.1016/j.jaccas.2026.107254.ABSTRACTBACKGROUND: Although left atrial appendage closure (LAAC) provides a crucial stroke prevention alternative for patients with atrial fibrillation (AF) who cannot undergo long-term anticoagulation, concurrent hypertrop
Quant Imaging Med Surg. 2026 Mar 1;16(3):197. doi: 10.21037/qims-2025-1631. Epub 2026 Feb 11.ABSTRACTBACKGROUND: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that increase the risk of cardiovascular disease. This study evaluated the impact of MetS on myocardial fibrosis, left he
Quant Imaging Med Surg. 2026 Mar 1;16(3):234. doi: 10.21037/qims-2025-1601. Epub 2026 Feb 11.ABSTRACTBACKGROUND: Obstructive coronary disease remains a leading cause of sudden cardiac death (SCD). The management of SCD therefore involves coronary angiography. Our aim was to evaluate whether the non-
Cardiovasc Diagn Ther. 2026 Feb 28;16(1):1. doi: 10.21037/cdt-2025-196. Epub 2026 Feb 11.ABSTRACTBACKGROUND: Atrial fibrillation (AF) is the most common type of arrhythmia in patients with hypertrophic cardiomyopathy (HCM) and may worsen their prognosis considerably. However, the effectiveness of ra
Am J Med Genet A. 2026 Mar 11. doi: 10.1002/ajmg.a.70120. Online ahead of print.ABSTRACTThe key diagnostic criterion for hypertrophic cardiomyopathy is the presence of otherwise unexplained hypertrophy. Current definitions of HCM rely on specific thresholds to establish a diagnosis, while guideline
No abstractJACC Cardiovasc Interv. 2026 Mar 9;19(5):615-617. doi: 10.1016/j.jcin.2025.10.039.NO ABSTRACTPMID:41813279 | DOI:10.1016/j.jcin.2025.10.039
J Arrhythm. 2026 Mar 8;42(2):e70308. doi: 10.1002/joa3.70308. eCollection 2026 Apr.ABSTRACTAIMS: Implantable cardioverter-defibrillator (ICD) therapy in children, particularly for primary prevention, remains under investigation, with limited data from less affluent European countries. With increasin
Mayo Clin Proc Innov Qual Outcomes. 2026 Mar 5;10(2):100706. doi: 10.1016/j.mayocpiqo.2026.100706. eCollection 2026 Apr.ABSTRACTMavacamten has emerged as an effective therapy for obstructive hypertrophic cardiomyopathy (oHCM); however, interindividual variability in maintenance dosing remains a prac
J Am Heart Assoc. 2026 Mar 10:e041231. doi: 10.1161/JAHA.125.041231. Online ahead of print.ABSTRACTBACKGROUND: In symptomatic patients with treatment-refractory obstructive hypertrophic cardiomyopathy, septal reduction therapy (SRT) is recommended to relieve obstruction. This study examined the chal
Rev Port Cardiol. 2026 Mar 7:S0870-2551(26)00062-4. doi: 10.1016/j.repc.2025.12.008. Online ahead of print.ABSTRACTINTRODUCTION AND OBJECTIVES: Implantable loop recorders (ILR) are increasingly being used for the detection of infrequent arrhythmias in patients with cardiomyopathies, especially in th
Egypt Heart J. 2026 Mar 9;78(1):16. doi: 10.1186/s43044-026-00727-6.ABSTRACTBACKGROUND: Heyde syndrome is an uncommon clinical condition characterized by the triad of aortic stenosis, gastrointestinal angiodysplasia, and acquired von Willebrand syndrome. Its occurrence in the context of hypertrophic
J Hypertens. 2026 Mar 6. doi: 10.1097/HJH.0000000000004283. Online ahead of print.ABSTRACTBACKGROUND AND AIM: Arterial hypertension is a major epidemiological risk factor for left ventricular hypertrophy (LVH) and heart failure (HF). Within this framework, the theory of hypertensive heart disease (H
Circulation. 2026 Mar 9. doi: 10.1161/CIRCULATIONAHA.125.076036. Online ahead of print.ABSTRACTBACKGROUND: Sarcomere gene variants are a key cause of hypertrophic cardiomyopathy (HCM), and have been associated with worse prognosis. However, it is unclear how comorbidities influence clinical trajecto
SAGE Open Med Case Rep. 2026 Mar 4;14:2050313X261429629. doi: 10.1177/2050313X261429629. eCollection 2026.ABSTRACTHypertrophic cardiomyopathy in infancy often follows a rapidly progressive clinical course, with many cases becoming fulminant and fatal. We reported a case of a 4-month-old infant with
Cureus. 2026 Feb 4;18(2):e102948. doi: 10.7759/cureus.102948. eCollection 2026 Feb.ABSTRACTBackground and objectives Pre-participation cardiovascular screening in athletes relies primarily on electrocardiography and transthoracic echocardiography. While cardiac magnetic resonance (CMR) is increasing
Eur J Pharmacol. 2026 Mar 6;1019:178715. doi: 10.1016/j.ejphar.2026.178715. Online ahead of print.ABSTRACTL-theanine (Thea), a non-protein amino acid derived from Camellia sinensis (green tea) has emerged as a promising nutraceutical for the prevention and treatment of cardiovascular diseases (CVDs)
No abstractBMC Med Imaging. 2026 Mar 7. doi: 10.1186/s12880-026-02257-8. Online ahead of print.NO ABSTRACTPMID:41794705 | DOI:10.1186/s12880-026-02257-8
Am J Cardiol. 2026 Mar 5:S0002-9149(26)00130-X. doi: 10.1016/j.amjcard.2026.03.002. Online ahead of print.ABSTRACTRecent advances in pre-procedural imaging have improved risk assessment and procedural planning for alcohol septal ablation (ASA) in patients with symptomatic obstructive hypertrophic ca
Metabolomics. 2026 Mar 7;22(2):37. doi: 10.1007/s11306-026-02412-w.ABSTRACTBACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease. Recent metabolomics studies have revealed pathogenic mechanisms and provided new perspectives for diagnosis.AIM: This study ai
J Feline Med Surg. 2026 Mar 6:1098612X261433060. doi: 10.1177/1098612X261433060. Online ahead of print.ABSTRACTOBJECTIVES: To investigate the effects of high-dose carvedilol treatment (HD) in client-owned cats with Stage B1 obstructive hypertrophic cardiomyopathy (oHCM) where standard-dose (SD) had
Magn Reson Imaging. 2026 Mar 4;129:110655. doi: 10.1016/j.mri.2026.110655. Online ahead of print.ABSTRACTOBJECTIVE: In hypertrophic cardiomyopathy (HCM), detection of coronary microcirculatory dysfunction (CMD) usually relies on contrast-enhanced cardiac magnetic resonance (CMR). This study sought t
